Prognia
Drug Database
🇪🇺EU · EMALapsedATC: V03AE

Fexeric(ferric citrate coordination complex)

Hyperphosphatemia;Renal Dialysis

Marketing Authorisation Holder: Akebia Europe Limited

EMA Authorisation: 23/09/2015

INN: ferric citrate coordination complex

Indication

Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fexeric — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.